Calamos Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-255,799
| Closed | -$25.4M | – | 846 |
|
|
2019
Q3 | $25.4M | Buy |
255,799
+19,454
| +8% | +$1.85M | 0.14% | 205 |
|
|
2019
Q2 | $21.8M | Sell |
236,345
-37,423
| -14% | -$3.55M | 0.12% | 218 |
|
|
2019
Q1 | $25.8M | Sell |
273,768
-154,295
| -36% | -$13.5M | 0.16% | 188 |
|
|
2018
Q4 | $27.4M | Buy |
428,063
+27,229
| +7% | +$2.01M | 0.18% | 167 |
|
|
2018
Q3 | $35.9M | Buy |
400,834
+11,827
| +3% | +$1.05M | 0.2% | 137 |
|
|
2018
Q2 | $30.9M | Buy |
389,007
+63,687
| +20% | +$5.29M | 0.19% | 147 |
|
|
2018
Q1 | $29M | Sell |
325,320
-334,930
| -51% | -$32.2M | 0.19% | 150 |
|
|
2017
Q4 | $68.9M | Sell |
660,250
-147,976
| -18% | -$16.7M | 0.35% | 45 |
|
|
2017
Q3 | $118M | Buy |
808,226
+22,083
| +3% | +$3.01M | 0.91% | 14 |
|
|
2017
Q2 | $102M | Buy |
786,143
+1,155
| +0.1% | +$142K | 0.75% | 20 |
|
|
2017
Q1 | $97.7M | Buy |
784,988
+18,328
| +2% | +$2.19M | 0.77% | 21 |
|
|
2016
Q4 | $88.7M | Sell |
766,660
-242,773
| -24% | -$27M | 0.71% | 27 |
|
|
2016
Q3 | $106M | Buy |
1,009,433
+105,743
| +12% | +$11.4M | 0.75% | 21 |
|
|
2016
Q2 | $89.1M | Sell |
903,690
-71,355
| -7% | -$7.38M | 0.63% | 31 |
|
|
2016
Q1 | $97.6M | Sell |
975,045
-212,660
| -18% | -$21.9M | 0.65% | 29 |
|
|
2015
Q4 | $142M | Buy |
1,187,705
+149,260
| +14% | +$17.3M | 0.9% | 19 |
|
|
2015
Q3 | $112M | Sell |
1,038,445
-26,108
| -2% | -$3.24M | 0.77% | 23 |
|
|
2015
Q2 | $123M | Buy |
1,064,553
+14,824
| +1% | +$1.69M | 0.76% | 23 |
|
|
2015
Q1 | $121M | Buy |
1,049,729
+63,134
| +6% | +$7.54M | 0.76% | 23 |
|
|
2014
Q4 | $110M | Sell |
986,595
-540,564
| -35% | -$57M | 0.73% | 27 |
|
|
2014
Q3 | $145M | Sell |
1,527,159
-46,797
| -3% | -$4.22M | 0.97% | 20 |
|
|
2014
Q2 | $135M | Buy |
1,573,956
+60,140
| +4% | +$4.57M | 0.86% | 28 |
|
|
2014
Q1 | $106M | Sell |
1,513,816
-328,246
| -18% | -$26M | 0.68% | 38 |
|
|
2013
Q4 | $156M | Sell |
1,842,062
-137,410
| -7% | -$10.9M | 0.99% | 22 |
|
|
2013
Q3 | $152M | Buy |
1,979,472
+516,322
| +35% | +$36.2M | 0.96% | 27 |
|
|
2013
Q2 | $85.5M | Buy |
+1,463,150
| New | +$88M | 0.56% | 50 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Calamos Advisors's CELG Position: Q4 2019 in Review
Calamos Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 255,799 shares — an estimated $25.4M sold.
Calamos Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $156M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Calamos Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Calamos Advisors sold 255,799 Celgene Corp shares in Q4 2019, an estimated $25.4M.
- Calamos Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Calamos Advisors's Celgene Corp position peaked at $156M in Q4 2013.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Calamos Advisors's 13F filing for Q4 2019, filed 15 Jan 2020.